ATE257386T1 - PHARMACEUTICAL COMPOSITIONS CONTAINING A MIXTURE OF SELF-CROSS-LINKED AND NON-SELF-CROSS-LINKED HYALURONIC ACID FOR THE TREATMENT OF ARTHROPATHIES - Google Patents

PHARMACEUTICAL COMPOSITIONS CONTAINING A MIXTURE OF SELF-CROSS-LINKED AND NON-SELF-CROSS-LINKED HYALURONIC ACID FOR THE TREATMENT OF ARTHROPATHIES

Info

Publication number
ATE257386T1
ATE257386T1 AT97930376T AT97930376T ATE257386T1 AT E257386 T1 ATE257386 T1 AT E257386T1 AT 97930376 T AT97930376 T AT 97930376T AT 97930376 T AT97930376 T AT 97930376T AT E257386 T1 ATE257386 T1 AT E257386T1
Authority
AT
Austria
Prior art keywords
self
cross
linked
hyaluronic acid
arthropathies
Prior art date
Application number
AT97930376T
Other languages
German (de)
Inventor
Davide Belini
Annamaria Paparella
Michael O'regan
Lanfranco Callegaro
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Application granted granted Critical
Publication of ATE257386T1 publication Critical patent/ATE257386T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to compositions containing an autocross-linked form of hyaluronic acid as a first component in a mixture with a second component noncross-linked hyaluronic acid, and possibly also in combination with another pharmacologically active substance. These compositions can be used in the treatment of arthropathies due to their unique viscoelastic properties.
AT97930376T 1996-06-21 1997-06-20 PHARMACEUTICAL COMPOSITIONS CONTAINING A MIXTURE OF SELF-CROSS-LINKED AND NON-SELF-CROSS-LINKED HYALURONIC ACID FOR THE TREATMENT OF ARTHROPATHIES ATE257386T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96PD000163A IT1288290B1 (en) 1996-06-21 1996-06-21 SELF-LETICULATED HYALURONIC ACID AND RELATED PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ARTHROPATHIES
PCT/EP1997/003238 WO1997049412A1 (en) 1996-06-21 1997-06-20 Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies

Publications (1)

Publication Number Publication Date
ATE257386T1 true ATE257386T1 (en) 2004-01-15

Family

ID=11391464

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97930376T ATE257386T1 (en) 1996-06-21 1997-06-20 PHARMACEUTICAL COMPOSITIONS CONTAINING A MIXTURE OF SELF-CROSS-LINKED AND NON-SELF-CROSS-LINKED HYALURONIC ACID FOR THE TREATMENT OF ARTHROPATHIES

Country Status (11)

Country Link
US (1) US6251876B1 (en)
EP (1) EP0954323B1 (en)
JP (1) JP2000512650A (en)
AT (1) ATE257386T1 (en)
AU (1) AU732979B2 (en)
CA (1) CA2258920C (en)
DE (1) DE69727158T2 (en)
ES (1) ES2214628T3 (en)
HK (1) HK1024865A1 (en)
IT (1) IT1288290B1 (en)
WO (1) WO1997049412A1 (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221854B1 (en) * 1996-03-05 2001-04-24 Orquest, Inc. Method of promoting bone growth with hyaluronic acid and growth factors
IT1296689B1 (en) * 1997-11-06 1999-07-14 Fidia Advanced Biopolymers Srl ESTERE DERIVATIVES OF HYALURONIC ACID HAVING VISCOELASTIC PROPERTIES AND THEIR USE IN THE BIOMEDICAL-HEALTH FIELD
US6824793B1 (en) 1998-06-01 2004-11-30 Chiron Corporation Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
CN1157191C (en) * 1998-11-10 2004-07-14 电气化学工业株式会社 Hyaluronic acid gel, process for preparation thereof and medical materials containing the same
IT1302534B1 (en) * 1998-12-21 2000-09-05 Fidia Advanced Biopolymers Srl INJECTABLE, BIOCOMPATIBLE AND BIODEGRADABLE COMPOSITIONS INCLUDING AT LEAST A DERIVATIVE OF HYALURONIC ACID, CHONDROGENIC CELLS, FOR
JP2003089647A (en) 1999-03-10 2003-03-28 Takada Seiyaku Kk Articular disease therapeutic agent
EP1454640A3 (en) * 1999-10-15 2004-09-22 Genetics Institute, LLC Formulations of hyaluronic acid for delivery of osteogenic proteins
ES2225241T3 (en) * 1999-10-15 2005-03-16 Genetics Institute, Llc HIALURONIC ACID FORMULATIONS TO SUPPLY OSTEOGENIC PROTEINS.
CN1259343C (en) * 2000-02-03 2006-06-14 电气化学工业株式会社 Hyaluronic acid gel, process for producing the same and medical material containing the same
US6638312B2 (en) * 2000-08-04 2003-10-28 Depuy Orthopaedics, Inc. Reinforced small intestinal submucosa (SIS)
US8366787B2 (en) 2000-08-04 2013-02-05 Depuy Products, Inc. Hybrid biologic-synthetic bioabsorbable scaffolds
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
US7819918B2 (en) 2001-07-16 2010-10-26 Depuy Products, Inc. Implantable tissue repair device
US7914808B2 (en) * 2001-07-16 2011-03-29 Depuy Products, Inc. Hybrid biologic/synthetic porous extracellular matrix scaffolds
US8025896B2 (en) 2001-07-16 2011-09-27 Depuy Products, Inc. Porous extracellular matrix scaffold and method
US20030032961A1 (en) 2001-07-16 2003-02-13 Pelo Mark Joseph Devices from naturally occurring biologically derived materials
US7201917B2 (en) * 2001-07-16 2007-04-10 Depuy Products, Inc. Porous delivery scaffold and method
WO2003007805A2 (en) * 2001-07-16 2003-01-30 Depuy Products, Inc. Cartilage repair apparatus and method
EP1416888A4 (en) 2001-07-16 2007-04-25 Depuy Products Inc Meniscus regeneration device and method
WO2003007787A2 (en) 2001-07-16 2003-01-30 Depuy Products, Inc. Cartilage repair and regeneration device and method
JPWO2003084571A1 (en) * 2002-04-08 2005-08-11 電気化学工業株式会社 Composition for treating bone infection
JP2005530768A (en) * 2002-05-09 2005-10-13 メディジーンズ Pharmaceutical composition for wound treatment containing plasma or serum
BR0310087A (en) 2002-05-17 2005-08-16 Wyeth Corp Hyaluronic acid injectable solid carriers for application of osteogenic proteins
US20040166169A1 (en) * 2002-07-15 2004-08-26 Prasanna Malaviya Porous extracellular matrix scaffold and method
NZ538266A (en) 2002-08-16 2007-05-31 Denki Kagaku Kogyo Kk Separate type medical material
US7465766B2 (en) * 2004-01-08 2008-12-16 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8138265B2 (en) * 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8137688B2 (en) * 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US6982298B2 (en) * 2003-01-10 2006-01-03 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US20040185022A1 (en) * 2003-02-19 2004-09-23 Steven Rubin Regimen for acne treatment
US20040167480A1 (en) * 2003-02-21 2004-08-26 Advanced Medical Optics, Inc. Administration of multiple viscoelastic solutions with a multi-compartment syringe
US20070224278A1 (en) * 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20120283232A9 (en) * 2003-11-12 2012-11-08 Zhengjun Wang Process for making a pharmaceutical composition
US8124120B2 (en) * 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
US8524213B2 (en) 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
US20050226936A1 (en) 2004-04-08 2005-10-13 Q-Med Ab Method of soft tissue augmentation
US7569233B2 (en) * 2004-05-04 2009-08-04 Depuy Products, Inc. Hybrid biologic-synthetic bioabsorbable scaffolds
US8017394B2 (en) * 2004-10-01 2011-09-13 Isto Technologies, Inc. Method for chondrocyte expansion with phenotype retention
US7273756B2 (en) 2004-10-01 2007-09-25 Isto Technologies, Inc. Method for chondrocyte expansion with phenotype retention
US7513866B2 (en) * 2004-10-29 2009-04-07 Depuy Products, Inc. Intestine processing device and associated method
US7323184B2 (en) * 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
US7871440B2 (en) 2006-12-11 2011-01-18 Depuy Products, Inc. Unitary surgical device and method
US9044477B2 (en) * 2007-12-12 2015-06-02 Allergan, Inc. Botulinum toxin formulation
WO2009102967A2 (en) 2008-02-13 2009-08-20 The Cleveland Clinic Foundation Molecular enhancement of extracellular matrix and methods of use
US8410180B2 (en) * 2008-04-30 2013-04-02 The Cleveland Clinic Foundation Methods to treat urinary incontinence
IT1395392B1 (en) † 2009-08-27 2012-09-14 Fidia Farmaceutici VISCOELASTIC FROSTS LIKE NEW FILLERS
CA2897467C (en) 2013-01-23 2020-09-22 Semnur Pharmaceuticals, Inc. Pharmaceutical formulation comprising an insoluble corticosteroid and a soluble corticosteroid
TWI674899B (en) 2015-01-21 2019-10-21 美商桑紐爾製藥公司 Pharmaceutical formulation
IT201900021693A1 (en) * 2019-11-20 2021-05-20 Bmg Pharma S P A BUTYRATED OR BUTYRATED DERIVATIVES AND FORMS OF CROSS-LINKED HYALURONIC ACID AND THEIR CROSS-LINKING PROCEDURE
EP4335876A1 (en) 2022-09-06 2024-03-13 Scivision Biotech Inc. Method of manufacturing auto-crosslinked hyaluronic acid gel and products thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1219587B (en) * 1988-05-13 1990-05-18 Fidia Farmaceutici SELF-CROSS-LINKED CARBOXYLY POLYSACCHARIDES
US5690961A (en) * 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses

Also Published As

Publication number Publication date
ES2214628T3 (en) 2004-09-16
CA2258920C (en) 2003-12-02
HK1024865A1 (en) 2000-10-27
AU3435497A (en) 1998-01-14
AU732979B2 (en) 2001-05-03
DE69727158D1 (en) 2004-02-12
DE69727158T2 (en) 2004-11-11
CA2258920A1 (en) 1997-12-31
IT1288290B1 (en) 1998-09-11
WO1997049412A1 (en) 1997-12-31
EP0954323A1 (en) 1999-11-10
EP0954323B1 (en) 2004-01-07
JP2000512650A (en) 2000-09-26
US6251876B1 (en) 2001-06-26
ITPD960163A1 (en) 1997-12-21

Similar Documents

Publication Publication Date Title
ATE257386T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A MIXTURE OF SELF-CROSS-LINKED AND NON-SELF-CROSS-LINKED HYALURONIC ACID FOR THE TREATMENT OF ARTHROPATHIES
ATE383169T1 (en) COMPONENT AND COMPOSITIONS FOR ADMINISTRATION OF ACTIVE INGREDIENTS
ATE249422T1 (en) COMPOUNDS AND COMPOSITIONS FOR ADMINISTRATION OF ACTIVE SUBSTANCES
DE69940769D1 (en) ORAL LIQUID COMPOSITIONS
DE69427704D1 (en) NEW (R) -5-CARBAMOYL-8-FLUOR-3-N, N-DISUBSTITUTED-AMINO-3,4-DIHYDRO-2H-1-BENZOPYRANE
ATE211384T1 (en) USE OF ADENOSINE ANTAGONISTS TO PREVENT AND TREAT PANCREATITIS AND ULCERAS
ATE202931T1 (en) MEDICINAL PREPARATIONS CONTAINING TAXAN DERIVATIVES
YU47116B (en) PROCEDURE FOR OBTAINING NEW N-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES
DE69932510D1 (en) VASKULARISIERUNGSINHIBITOREN
ATE243196T1 (en) PIPERIDINE AND PYRROLIDINE
DE69034226D1 (en) Preparation process of huperzine A and its analogs and compounds useful thereto
DE69803773T2 (en) COMPOSITION CONTAINING YOHIMBINE AND ARGININE FOR TREATING ERECTILE MALFUNCTION
TR200402070T4 (en) Cyclobutene-dione derivatives and their use in the treatment of arteriosclerosis
ATE213233T1 (en) SUBSTITUTED CAPROLACTAMES AND THEIR DERIVATIVES USABLE FOR THE TREATMENT OF HIV DISEASE
NO20015398D0 (en) Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines
BR9708720A (en) Pharmaceutical composition and process for the treatment of HIV dementia.
ATE209040T1 (en) METHODS AND COMPOSITIONS FOR PREVENTING INFLAMMATION CAUSED BY ENDOTHELIAL CELLS AND FIBRINOGEN
DE3777411D1 (en) AGENTS FOR IMPROVING PERCUTANEOUS ADMINISTRATION OF MEDICINAL PRODUCTS.
DE69838981D1 (en) Component and compositions for the administration of active ingredients

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0954323

Country of ref document: EP